RICK CHARLES CHATWELL M.D. NPI 1841260478

NPI Information

  • NPI: 1841260478
  • Provider Name: RICK CHARLES CHATWELL, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3901 PINE LAKE RD
    SUITE 120
    LINCOLN, NE
    ZIP 68516
  • Phone: (402) 420-1212

Map and Directions

Get Directions

NPI Details

Rick Charles Chatwell, M.D. is a rheumatology internal medicine in Lincoln, NE. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Rick Charles Chatwell, M.D. NPI is 1841260478. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3901 PINE LAKE RD
SUITE 120
LINCOLN, NE
ZIP 68516-497
Phone: (402) 420-1212
Fax: (402) 328-0961

The NPI 1841260478 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood creatinine level (HCPCS:82565)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Albumin (protein) level (HCPCS:82040)
  • Blood potassium level (HCPCS:84132)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Calcium level, total (HCPCS:82310)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Vitamin d-3 level (HCPCS:82306)
  • Uric acid level, blood (HCPCS:84550)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Automated urinalysis test (HCPCS:81003)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Total protein level, urine (HCPCS:84156)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • X-ray of knee, 4 or more views (HCPCS:73564)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • Phosphate level (HCPCS:84100)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Carbon dioxide (bicarbonate) level (HCPCS:82374)
  • X-ray of middle and lower spine, 2 views (HCPCS:72080)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)

The enumeration date for this NPI number is 1/25/2006 and was last updated on 4/28/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology18412NEBRASKAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
103461/01942OTHERBLUE SHIELD PIN/GROUP
2110047262/CO4240OTHERRAILROAD MEDICARE PIN/GRP

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.